News | July 28, 2009

NYU School of Medicine Installs ClearVue Prone Breast Table

July 27, 2009 – Orbital Therapy announces the installation of ClearVue prone breast tables in the radiation therapy department of New York University School of Medicine.
Orbital Therapy’s all carbon fiber ClearVue prone position table addresses current and future requirements to deliver this emerging therapy technique. Placing the patient in the prone position reportedly reduces target motion, increases the separation between the target anatomy and critical structures such as lung and heart, and allows for better localization of the treatment area.
ClearVue's patent-pending open design provides visual and treatment access to the breast, allowing the physician to plan and treat from multiple angles.
The interchangeable mid-section allows you to quickly change the table configuration using various inserts, available in a number of different sizes and shapes.

For more information: www.orbitaltherapy.com

Related Content

RayStation Replacing Existing Treatment Planning System at Leeds Cancer Centre
News | Treatment Planning | September 24, 2018
RaySearch recently strengthened its position in the U.K. market with a major order for the treatment planning system...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...